Why partner with AstraZeneca?

We have a global commercial presence and strength in emerging markets, particularly in China. Our innovative medicines, many of which are developed in partnership with others, are used by millions of patients worldwide.



$22.1bn

total revenue

$1bn

externalisation revenue

260+

major or strategically important deals in last 3 years

630+

collaborations worldwide help us access the best science, stimulate innovation and accelerate delivery of new medicines for unmet medical needs


64,600

employees

25

manufacturing sites in 16 countries

$5.9bn

invested in R&D

90%

of pipeline has a precision medicine approach


For year ending 31 December 2018
 


Pushing the boundaries of science to deliver life-changing medicines

Science is what drives AstraZeneca. We keep pushing the boundaries of science to deliver life-changing medicines that address significant unmet medical need in diseases affecting millions of people around the world.




Encouraging innovation and inspiring the next generation of start-ups



Veeva ID: Z4-21504
Date of Prep: Dec 2019
Expiry Date: Dec 2020